$ELGX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENDOLOGIX INC /DE/.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ENDOLOGIX INC /DE/. Get notifications about new insider transactions in ENDOLOGIX INC /DE/ for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17 2020 | ELGX | ENDOLOGIX INC /DE/ | Lemaitre Dan | Director | Sell | S | 0.05 | 15,553 | 810 | 0 | 15.6 K to 0 (-100.00 %) |
| Sep 17 2020 | ELGX | ENDOLOGIX INC /DE/ | Lemaitre Dan | Director | Sell | S | 0.05 | 33,709 | 1,689 | 15,553 | 49.3 K to 15.6 K (-68.43 %) |
| Sep 17 2020 | ELGX | ENDOLOGIX INC /DE/ | Lemaitre Dan | Director | Sell | S | 0.05 | 2,582 | 129 | 49,262 | 51.8 K to 49.3 K (-4.98 %) |
| Aug 19 2020 | ELGX | ENDOLOGIX INC /DE/ | Lemaitre Dan | Director | Sell | S | 0.08 | 1,127 | 92 | 51,844 | 53 K to 51.8 K (-2.13 %) |
| Aug 19 2020 | ELGX | ENDOLOGIX INC /DE/ | Lemaitre Dan | Director | Sell | S | 0.09 | 1,126 | 98 | 52,971 | 54.1 K to 53 K (-2.08 %) |
| Aug 14 2020 | ELGX | ENDOLOGIX INC /DE/ | Brady Timothy Nicholas | Controller and Corp ... | Sell | S | 0.09 | 113 | 10 | 891 | 1 K to 891 (-11.25 %) |
| Aug 14 2020 | ELGX | ENDOLOGIX INC /DE/ | Brady Timothy Nicholas | Controller and Corp ... | Sell | S | 0.08 | 1,628 | 132 | 1,004 | 2.6 K to 1 K (-61.85 %) |
| Aug 14 2020 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Sell | S | 0.08 | 12,088 | 1,009 | 0 | 12.1 K to 0 (-100.00 %) |
| Aug 14 2020 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Sell | S | 0.08 | 15,776 | 1,262 | 12,088 | 27.9 K to 12.1 K (-56.62 %) |
| Aug 14 2020 | ELGX | ENDOLOGIX INC /DE/ | Thompson Matthew | Chief Medical Offic ... | Sell | S | 0.09 | 21,888 | 1,926 | 52,878 | 74.8 K to 52.9 K (-29.28 %) |
| Aug 14 2020 | ELGX | ENDOLOGIX INC /DE/ | Pinto Cynthia Buch | Interim CFO | Sell | S | 0.09 | 12,003 | 1,056 | 6,304 | 18.3 K to 6.3 K (-65.57 %) |
| Aug 14 2020 | ELGX | ENDOLOGIX INC /DE/ | WALLER GREGORY D | Director | Sell | S | 0.08 | 28,630 | 2,402 | 710 | 29.3 K to 710 (-97.58 %) |
| Aug 14 2020 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | CEO and Director | Sell | S | 0.08 | 30,257 | 2,514 | 165,698 | 196 K to 165.7 K (-15.44 %) |
| Aug 14 2020 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | CEO and Director | Sell | S | 0.09 | 1,306 | 115 | 195,955 | 197.3 K to 196 K (-0.66 %) |
| Aug 14 2020 | ELGX | ENDOLOGIX INC /DE/ | WALLER GREGORY D | Director | Sell | S | 0.08 | 28,630 | 2,402 | 710 | 29.3 K to 710 (-97.58 %) |
| Aug 14 2020 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | CEO and Director | Sell | S | 0.88 | 57,415 | 50,726 | 197,261 | 254.7 K to 197.3 K (-22.54 %) |
| Aug 14 2020 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | CEO and Director | Sell | S | 0.08 | 30,257 | 2,514 | 165,698 | 196 K to 165.7 K (-15.44 %) |
| Aug 14 2020 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | CEO and Director | Sell | S | 0.09 | 1,306 | 115 | 195,955 | 197.3 K to 196 K (-0.66 %) |
| Aug 14 2020 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | CEO and Director | Sell | S | 0.88 | 57,415 | 50,726 | 197,261 | 254.7 K to 197.3 K (-22.54 %) |
| Aug 07 2020 | ELGX | ENDOLOGIX INC /DE/ | Pinto Cynthia Buch | Interim CFO | Grant | A | 0.07 | 891 | 62 | 23,658 | 24.5 K to 23.7 K (-3.63 %) |
| Aug 07 2020 | ELGX | ENDOLOGIX INC /DE/ | Pinto Cynthia Buch | Interim CFO | Grant | A | 0.00 | 24,410 | 0 | 24,549 | 139 to 24.5 K (+17,561.15 %) |
| Aug 07 2020 | ELGX | ENDOLOGIX INC /DE/ | Fecho Jeff | Chief Quality Offic ... | Sell | D | 0.07 | 1,946 | 136 | 23,732 | 25.7 K to 23.7 K (-7.58 %) |
| Aug 07 2020 | ELGX | ENDOLOGIX INC /DE/ | Fecho Jeff | Chief Quality Offic ... | Grant | A | 0.00 | 20,700 | 0 | 25,678 | 5 K to 25.7 K (+415.83 %) |
| Aug 07 2020 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | CEO and Director | Grant | A | 0.07 | 9,424 | 658 | 254,176 | 263.6 K to 254.2 K (-3.58 %) |
| Aug 07 2020 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | CEO and Director | Grant | A | 0.00 | 167,870 | 0 | 263,600 | 95.7 K to 263.6 K (+175.36 %) |
| Aug 07 2020 | ELGX | ENDOLOGIX INC /DE/ | Thompson Matthew | Chief Medical Offic ... | Sell | D | 0.07 | 3,417 | 239 | 74,766 | 78.2 K to 74.8 K (-4.37 %) |
| Aug 07 2020 | ELGX | ENDOLOGIX INC /DE/ | Thompson Matthew | Chief Medical Offic ... | Buy | D | 0.00 | 30,433 | 0 | 78,183 | 47.8 K to 78.2 K (+63.73 %) |
| Jun 26 2020 | ELGX | ENDOLOGIX INC /DE/ | Fecho Jeff | Chief Quality Offic ... | Payment of Exercise | F | 0.85 | 693 | 588 | 25,678 | 26.4 K to 25.7 K (-2.63 %) |
| Jun 26 2020 | ELGX | ENDOLOGIX INC /DE/ | Fecho Jeff | Chief Quality Offic ... | Grant | A | 0.00 | 6,172 | 0 | 26,371 | 20.2 K to 26.4 K (+30.56 %) |
| May 05 2020 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | CEO and Director | Payment of Exercise | F | 0.89 | 6,968 | 6,187 | 263,600 | 270.6 K to 263.6 K (-2.58 %) |
| May 05 2020 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | CEO and Director | Grant | A | 0.00 | 60,443 | 0 | 270,568 | 210.1 K to 270.6 K (+28.77 %) |
| Mar 26 2020 | ELGX | ENDOLOGIX INC /DE/ | Mahboob Vaseem | Chief Financial Off ... | Payment of Exercise | F | 0.94 | 3,625 | 3,408 | 111,716 | 115.3 K to 111.7 K (-3.14 %) |
| Mar 26 2020 | ELGX | ENDOLOGIX INC /DE/ | Mahboob Vaseem | Chief Financial Off ... | Grant | A | 0.00 | 47,010 | 0 | 115,341 | 68.3 K to 115.3 K (+68.80 %) |
| Mar 18 2020 | ELGX | ENDOLOGIX INC /DE/ | Kiernan Jane E | Director | Grant | A | 0.00 | 103,847 | 0 | 103,847 | 0 to 103.8 K |
| Jan 09 2020 | ELGX | ENDOLOGIX INC /DE/ | Zehren John | Chief Commercial Of ... | Payment of Exercise | F | 1.98 | 2,726 | 5,397 | 40,138 | 42.9 K to 40.1 K (-6.36 %) |
| Jan 09 2020 | ELGX | ENDOLOGIX INC /DE/ | Zehren John | Chief Commercial Of ... | Grant | A | 0.00 | 20,000 | 0 | 42,864 | 22.9 K to 42.9 K (+87.47 %) |
| Jan 02 2020 | ELGX | ENDOLOGIX INC /DE/ | Thompson Matthew | Chief Medical Offic ... | Payment of Exercise | F | 1.68 | 5,278 | 8,867 | 78,966 | 84.2 K to 79 K (-6.27 %) |
| Jan 02 2020 | ELGX | ENDOLOGIX INC /DE/ | Thompson Matthew | Chief Medical Offic ... | Grant | A | 0.00 | 47,011 | 0 | 84,244 | 37.2 K to 84.2 K (+126.26 %) |
| Dec 17 2019 | ELGX | ENDOLOGIX INC /DE/ | Mahboob Vaseem | Chief Financial Off ... | Payment of Exercise | F | 2.55 | 2,986 | 7,599 | 118,733 | 121.7 K to 118.7 K (-2.45 %) |
| Dec 17 2019 | ELGX | ENDOLOGIX INC /DE/ | Mahboob Vaseem | Chief Financial Off ... | Grant | A | 0.00 | 47,010 | 0 | 121,719 | 74.7 K to 121.7 K (+62.92 %) |
| Nov 13 2019 | ELGX | ENDOLOGIX INC /DE/ | WALLER GREGORY D | Director | Sell | S | 3.00 | 582 | 1,746 | 29,340 | 29.9 K to 29.3 K (-1.95 %) |
| Nov 13 2019 | ELGX | ENDOLOGIX INC /DE/ | WALLER GREGORY D | Director | Sell | S | 3.00 | 582 | 1,746 | 29,340 | 29.9 K to 29.3 K (-1.95 %) |
| Oct 07 2019 | ELGX | ENDOLOGIX INC /DE/ | HAYDEN JEREMY B. | General Counsel | Payment of Exercise | F | 3.53 | 4,210 | 14,861 | 32,040 | 36.3 K to 32 K (-11.61 %) |
| Oct 07 2019 | ELGX | ENDOLOGIX INC /DE/ | HAYDEN JEREMY B. | General Counsel | Grant | A | 0.00 | 12,500 | 0 | 36,250 | 23.8 K to 36.3 K (+52.63 %) |
| Oct 01 2019 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | CEO and Director | Option Exercise | A | 4.71 | 12,968 | 61,079 | 12,968 | |
| Oct 01 2019 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | CEO and Director | Option Exercise | D | 43.60 | 19,864 | 866,070 | 0 | |
| Oct 01 2019 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | CEO and Director | Option Exercise | D | 53.00 | 19,034 | 1,008,802 | 0 | |
| Oct 01 2019 | ELGX | ENDOLOGIX INC /DE/ | Fecho Jeff | Chief Quality Offic ... | Option Exercise | A | 4.71 | 2,263 | 10,659 | 2,263 | |
| Oct 01 2019 | ELGX | ENDOLOGIX INC /DE/ | Fecho Jeff | Chief Quality Offic ... | Option Exercise | D | 56.70 | 6,789 | 384,936 | 0 | |
| Oct 01 2019 | ELGX | ENDOLOGIX INC /DE/ | Mahboob Vaseem | Chief Financial Off ... | Option Exercise | A | 4.71 | 10,959 | 51,617 | 10,959 | |
| Oct 01 2019 | ELGX | ENDOLOGIX INC /DE/ | Mahboob Vaseem | Chief Financial Off ... | Option Exercise | D | 48.20 | 10,999 | 530,152 | 0 | |
| Oct 01 2019 | ELGX | ENDOLOGIX INC /DE/ | Mahboob Vaseem | Chief Financial Off ... | Option Exercise | D | 75.30 | 11,594 | 873,028 | 0 | |
| Oct 01 2019 | ELGX | ENDOLOGIX INC /DE/ | Mahboob Vaseem | Chief Financial Off ... | Option Exercise | D | 135.60 | 13,702 | 1,857,991 | 0 | |
| Oct 01 2019 | ELGX | ENDOLOGIX INC /DE/ | Lemaitre Dan | Director | Option Exercise | A | 4.71 | 2,834 | 13,348 | 2,834 | |
| Oct 01 2019 | ELGX | ENDOLOGIX INC /DE/ | Lemaitre Dan | Director | Option Exercise | D | 82.60 | 2,000 | 165,200 | 0 | |
| Oct 01 2019 | ELGX | ENDOLOGIX INC /DE/ | Lemaitre Dan | Director | Option Exercise | D | 43.60 | 2,000 | 87,200 | 0 | |
| Oct 01 2019 | ELGX | ENDOLOGIX INC /DE/ | Lemaitre Dan | Director | Option Exercise | D | 43.80 | 5,000 | 219,000 | 0 | |
| Oct 01 2019 | ELGX | ENDOLOGIX INC /DE/ | HAYDEN JEREMY B. | General Counsel | Option Exercise | A | 4.71 | 7,868 | 37,058 | 7,868 | |
| Oct 01 2019 | ELGX | ENDOLOGIX INC /DE/ | HAYDEN JEREMY B. | General Counsel | Option Exercise | D | 42.10 | 23,601 | 993,602 | 0 | |
| Aug 15 2019 | ELGX | ENDOLOGIX INC /DE/ | WALLER GREGORY D | Director | Sell | S | 6.61 | 715 | 4,726 | 29,922 | 30.6 K to 29.9 K (-2.33 %) |
| Aug 15 2019 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Sell | S | 6.61 | 1,369 | 9,049 | 27,864 | 29.2 K to 27.9 K (-4.68 %) |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | Zenty III Thomas F | Director | Option Exercise | A | 6.67 | 9,023 | 60,183 | 9,023 | |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | Zenty III Thomas F | Director | Grant | A | 0.00 | 13,494 | 0 | 35,547 | 22.1 K to 35.5 K (+61.19 %) |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | CEO and Director | Option Exercise | A | 6.67 | 497,041 | 3,315,263 | 497,041 | |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | CEO and Director | Grant | A | 0.00 | 167,870 | 0 | 270,068 | 102.2 K to 270.1 K (+164.26 %) |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | Lemaitre Dan | Director | Option Exercise | A | 6.67 | 21,913 | 146,160 | 21,913 | |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | Lemaitre Dan | Director | Grant | A | 0.00 | 13,494 | 0 | 46,601 | 33.1 K to 46.6 K (+40.76 %) |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | HAYDEN JEREMY B. | General Counsel | Option Exercise | A | 6.67 | 38,000 | 253,460 | 38,000 | |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | HAYDEN JEREMY B. | General Counsel | Grant | A | 0.00 | 19,000 | 0 | 36,250 | 17.3 K to 36.3 K (+110.14 %) |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | Zehren John | Chief Commercial Of ... | Option Exercise | A | 6.67 | 30,600 | 204,102 | 30,600 | |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | Zehren John | Chief Commercial Of ... | Grant | A | 0.00 | 15,300 | 0 | 42,864 | 27.6 K to 42.9 K (+55.51 %) |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | Fecho Jeff | Chief Quality Offic ... | Option Exercise | A | 6.67 | 41,400 | 276,138 | 41,400 | |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | Fecho Jeff | Chief Quality Offic ... | Grant | A | 0.00 | 20,700 | 0 | 26,371 | 5.7 K to 26.4 K (+365.01 %) |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | Norwalk Leslie V | Director | Option Exercise | A | 6.67 | 9,023 | 60,183 | 9,023 | |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | Norwalk Leslie V | Director | Grant | A | 0.00 | 13,494 | 0 | 29,932 | 16.4 K to 29.9 K (+82.09 %) |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Option Exercise | A | 6.67 | 9,023 | 60,183 | 9,023 | |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Grant | A | 0.00 | 13,494 | 0 | 29,233 | 15.7 K to 29.2 K (+85.74 %) |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | Mahboob Vaseem | Chief Financial Off ... | Option Exercise | A | 6.67 | 64,800 | 432,216 | 64,800 | |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | Mahboob Vaseem | Chief Financial Off ... | Grant | A | 0.00 | 32,400 | 0 | 121,720 | 89.3 K to 121.7 K (+36.27 %) |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | WALLER GREGORY D | Director | Option Exercise | A | 6.67 | 9,023 | 60,183 | 9,023 | |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | WALLER GREGORY D | Director | Grant | A | 0.00 | 13,494 | 0 | 30,637 | 17.1 K to 30.6 K (+78.71 %) |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | Thompson Matthew | Chief Medical Offic ... | Option Exercise | A | 6.67 | 60,867 | 405,983 | 60,867 | |
| Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | Thompson Matthew | Chief Medical Offic ... | Grant | A | 0.00 | 30,433 | 0 | 84,244 | 53.8 K to 84.2 K (+56.56 %) |
| Jun 27 2019 | ELGX | ENDOLOGIX INC /DE/ | Fecho Jeff | Chief Quality Offic ... | Payment of Exercise | F | 7.87 | 712 | 5,603 | 5,671 | 6.4 K to 5.7 K (-11.15 %) |
| Jun 27 2019 | ELGX | ENDOLOGIX INC /DE/ | Fecho Jeff | Chief Quality Offic ... | Grant | A | 0.00 | 6,172 | 0 | 6,383 | 211 to 6.4 K (+2,925.12 %) |
| May 10 2019 | ELGX | ENDOLOGIX INC /DE/ | Thompson Matthew | Chief Medical Offic ... | Payment of Exercise | F | 6.40 | 421 | 2,694 | 53,811 | 54.2 K to 53.8 K (-0.78 %) |
| May 10 2019 | ELGX | ENDOLOGIX INC /DE/ | Thompson Matthew | Chief Medical Offic ... | Grant | A | 0.00 | 1,250 | 0 | 54,232 | 53 K to 54.2 K (+2.36 %) |
| May 09 2019 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Sell | S | 6.34 | 1,455 | 9,224 | 15,739 | 17.2 K to 15.7 K (-8.46 %) |
| May 03 2019 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | CEO and Director | Payment of Exercise | F | 6.32 | 6,968 | 44,038 | 101,892 | 108.9 K to 101.9 K (-6.40 %) |
| May 03 2019 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | CEO and Director | Grant | A | 0.00 | 60,443 | 0 | 108,860 | 48.4 K to 108.9 K (+124.84 %) |
| Apr 03 2019 | ELGX | ENDOLOGIX INC /DE/ | Mahboob Vaseem | Chief Financial Off ... | Grant | A | 0.00 | 12,500 | 0 | 89,320 | 76.8 K to 89.3 K (+16.27 %) |
| Apr 03 2019 | ELGX | ENDOLOGIX INC /DE/ | Mahboob Vaseem | Chief Financial Off ... | Buy | P | 6.61 | 15,128 | 99,996 | 76,820 | 61.7 K to 76.8 K (+24.52 %) |
| Apr 03 2019 | ELGX | ENDOLOGIX INC /DE/ | HAYDEN JEREMY B. | General Counsel | Grant | A | 0.00 | 12,500 | 0 | 17,250 | 4.8 K to 17.3 K (+263.16 %) |
| Apr 03 2019 | ELGX | ENDOLOGIX INC /DE/ | Zenty III Thomas F | Director | Buy | P | 6.61 | 3,025 | 19,995 | 22,053 | 19 K to 22.1 K (+15.90 %) |
| Apr 03 2019 | ELGX | ENDOLOGIX INC /DE/ | NEELS GUIDO J | Director | Buy | P | 6.61 | 22,692 | 149,994 | 43,200 | 20.5 K to 43.2 K (+110.65 %) |
| Feb 01 2019 | ELGX | ENDOLOGIX INC /DE/ | Thompson Matthew | Chief Medical Offic ... | Grant | A | 0.00 | 19,142 | 0 | 542,319 | 523.2 K to 542.3 K (+3.66 %) |
| Jan 03 2019 | ELGX | ENDOLOGIX INC /DE/ | NEELS GUIDO J | Director | Grant | A | 0.00 | 120,887 | 0 | 205,089 | 84.2 K to 205.1 K (+143.57 %) |
| Jan 02 2019 | ELGX | ENDOLOGIX INC /DE/ | Thompson Matthew | Chief Medical Offic ... | Option Exercise | A | 0.74 | 225,621 | 167,975 | 225,621 | |
| Jan 02 2019 | ELGX | ENDOLOGIX INC /DE/ | Thompson Matthew | Chief Medical Offic ... | Grant | A | 0.00 | 470,115 | 0 | 523,177 | 53.1 K to 523.2 K (+885.97 %) |
| Jan 02 2019 | ELGX | ENDOLOGIX INC /DE/ | Thompson Matthew | Chief Medical Offic ... | Sell | D | 0.00 | 15,000 | 0 | 53,062 | 68.1 K to 53.1 K (-22.04 %) |
| Jan 02 2019 | ELGX | ENDOLOGIX INC /DE/ | Mahboob Vaseem | Chief Financial Off ... | Option Exercise | A | 0.74 | 225,621 | 167,975 | 225,621 | |
| Jan 02 2019 | ELGX | ENDOLOGIX INC /DE/ | Mahboob Vaseem | Chief Financial Off ... | Grant | A | 0.00 | 470,115 | 0 | 616,927 | 146.8 K to 616.9 K (+320.22 %) |
| Jan 02 2019 | ELGX | ENDOLOGIX INC /DE/ | WALLER GREGORY D | Director | Grant | A | 0.00 | 120,887 | 0 | 171,437 | 50.6 K to 171.4 K (+239.14 %) |
| Jan 02 2019 | ELGX | ENDOLOGIX INC /DE/ | HAYDEN JEREMY B. | General Counsel | Option Exercise | A | 0.74 | 216,449 | 161,146 | 216,449 | |
| Jan 02 2019 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | CEO and Director | Grant | A | 0.00 | 604,433 | 0 | 661,037 | 56.6 K to 661 K (+1,067.83 %) |
| Jan 02 2019 | ELGX | ENDOLOGIX INC /DE/ | Norwalk Leslie V | Director | Grant | A | 0.00 | 120,887 | 0 | 164,378 | 43.5 K to 164.4 K (+277.96 %) |
| Jan 02 2019 | ELGX | ENDOLOGIX INC /DE/ | Lemaitre Dan | Director | Grant | A | 0.00 | 181,330 | 0 | 331,065 | 149.7 K to 331.1 K (+121.10 %) |
| Jan 02 2019 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Grant | A | 0.00 | 120,887 | 0 | 171,947 | 51.1 K to 171.9 K (+236.75 %) |
| Jan 02 2019 | ELGX | ENDOLOGIX INC /DE/ | Zenty III Thomas F | Director | Grant | A | 0.00 | 120,887 | 0 | 190,283 | 69.4 K to 190.3 K (+174.20 %) |
| Aug 20 2018 | ELGX | ENDOLOGIX INC /DE/ | Mahboob Vaseem | Chief Financial Off ... | Buy | P | 2.43 | 30,000 | 72,900 | 146,812 | 116.8 K to 146.8 K (+25.68 %) |
| Jun 01 2018 | ELGX | ENDOLOGIX INC /DE/ | Thompson Matthew | Chief Medical Offic ... | Payment of Exercise | F | 4.87 | 10,719 | 52,202 | 68,692 | 79.4 K to 68.7 K (-13.50 %) |
| Jun 01 2018 | ELGX | ENDOLOGIX INC /DE/ | Thompson Matthew | Chief Medical Offic ... | Grant | A | 0.00 | 31,000 | 0 | 79,411 | 48.4 K to 79.4 K (+64.04 %) |
| May 30 2018 | ELGX | ENDOLOGIX INC /DE/ | Chavez Christopher G. | Director | Sell | S | 5.70 | 8 | 46 | 378,346 | 378.4 K to 378.3 K (0.00 %) |
| May 30 2018 | ELGX | ENDOLOGIX INC /DE/ | Chavez Christopher G. | Director | Sell | S | 5.64 | 8 | 45 | 378,354 | 378.4 K to 378.4 K (0.00 %) |
| May 30 2018 | ELGX | ENDOLOGIX INC /DE/ | McDermott John D | Director | Payment of Exercise | F | 5.65 | 7,286 | 41,166 | 879,423 | 886.7 K to 879.4 K (-0.82 %) |
| May 30 2018 | ELGX | ENDOLOGIX INC /DE/ | McDermott John D | Director | Grant | A | 0.00 | 48,222 | 0 | 886,709 | 838.5 K to 886.7 K (+5.75 %) |
| May 14 2018 | ELGX | ENDOLOGIX INC /DE/ | McDermott John D | Director | Option Exercise | M | 2.67 | 177,065 | 472,764 | 0 | |
| May 14 2018 | ELGX | ENDOLOGIX INC /DE/ | McDermott John D | Director | Payment of Exercise | F | 4.73 | 133,503 | 631,469 | 886,709 | 1 M to 886.7 K (-13.09 %) |
| May 14 2018 | ELGX | ENDOLOGIX INC /DE/ | McDermott John D | Director | Buy | M | 2.67 | 177,065 | 472,764 | 1,020,212 | 843.1 K to 1 M (+21.00 %) |
| May 11 2018 | ELGX | ENDOLOGIX INC /DE/ | Lemaitre Dan | Director | Grant | A | 0.00 | 46,814 | 0 | 149,735 | 102.9 K to 149.7 K (+45.49 %) |
| May 04 2018 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | Chief Executive Off ... | Option Exercise | A | 4.36 | 198,650 | 866,114 | 198,650 | |
| Mar 28 2018 | ELGX | ENDOLOGIX INC /DE/ | McDermott John D | Chief Executive Off ... | Option Exercise | M | 2.67 | 250,000 | 667,500 | 155,381 | |
| Mar 28 2018 | ELGX | ENDOLOGIX INC /DE/ | McDermott John D | Chief Executive Off ... | Buy | M | 2.67 | 250,000 | 667,500 | 838,659 | 588.7 K to 838.7 K (+42.47 %) |
| Mar 15 2018 | ELGX | ENDOLOGIX INC /DE/ | McDermott John D | Chief Executive Off ... | Sell | D | 0.00 | 140,000 | 0 | 588,659 | 728.7 K to 588.7 K (-19.21 %) |
| Mar 15 2018 | ELGX | ENDOLOGIX INC /DE/ | McDermott John D | Chief Executive Off ... | Sell | D | 0.00 | 140,000 | 0 | 588,659 | 728.7 K to 588.7 K (-19.21 %) |
| Mar 15 2018 | ELGX | ENDOLOGIX INC /DE/ | Mahboob Vaseem | VP, Quality | Sell | D | 0.00 | 28,000 | 0 | 116,812 | 144.8 K to 116.8 K (-19.34 %) |
| Mar 15 2018 | ELGX | ENDOLOGIX INC /DE/ | Mahboob Vaseem | VP, Quality | Sell | D | 0.00 | 28,000 | 0 | 116,812 | 144.8 K to 116.8 K (-19.34 %) |
| Mar 15 2018 | ELGX | ENDOLOGIX INC /DE/ | Nagel Laura | VP, Quality | Sell | D | 0.00 | 5,000 | 0 | 48,860 | 53.9 K to 48.9 K (-9.28 %) |
| Feb 09 2018 | ELGX | ENDOLOGIX INC /DE/ | McDermott John D | Chief Executive Off ... | Payment of Exercise | F | 4.05 | 14,467 | 58,591 | 728,659 | 743.1 K to 728.7 K (-1.95 %) |
| Feb 09 2018 | ELGX | ENDOLOGIX INC /DE/ | McDermott John D | Chief Executive Off ... | Grant | A | 0.00 | 106,242 | 0 | 743,126 | 636.9 K to 743.1 K (+16.68 %) |
| Feb 09 2018 | ELGX | ENDOLOGIX INC /DE/ | Mahboob Vaseem | Chief Financial Off ... | Payment of Exercise | F | 4.05 | 4,632 | 18,760 | 144,812 | 149.4 K to 144.8 K (-3.10 %) |
| Feb 09 2018 | ELGX | ENDOLOGIX INC /DE/ | Mahboob Vaseem | Chief Financial Off ... | Grant | A | 0.00 | 33,201 | 0 | 149,444 | 116.2 K to 149.4 K (+28.56 %) |
| Nov 08 2017 | ELGX | ENDOLOGIX INC /DE/ | Mahboob Vaseem | Chief Financial Off ... | Grant | A | 0.00 | 25,000 | 0 | 149,444 | 124.4 K to 149.4 K (+20.09 %) |
| Nov 01 2017 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | Chief Operating Off ... | Option Exercise | A | 5.30 | 187,484 | 993,665 | 187,484 | |
| Nov 01 2017 | ELGX | ENDOLOGIX INC /DE/ | Onopchenko John | Chief Operating Off ... | Grant | A | 0.00 | 56,604 | 0 | 56,604 | 0 to 56.6 K |
| Jun 20 2017 | ELGX | ENDOLOGIX INC /DE/ | Mitchell Robert D | President | Sell | D | 0.00 | 18,083 | 0 | 316,886 | 335 K to 316.9 K (-5.40 %) |
| Jun 20 2017 | ELGX | ENDOLOGIX INC /DE/ | McDermott John D | Chief Executive Off ... | Sell | D | 0.00 | 48,222 | 0 | 743,126 | 791.3 K to 743.1 K (-6.09 %) |
| Jun 06 2017 | ELGX | ENDOLOGIX INC /DE/ | O'Quinn Shari L | VP, Clinical & Regu ... | Option Exercise | A | 4.82 | 65,000 | 313,300 | 65,000 | |
| Jun 06 2017 | ELGX | ENDOLOGIX INC /DE/ | O'Quinn Shari L | VP, Clinical & Regu ... | Grant | A | 0.00 | 18,000 | 0 | 94,356 | 76.4 K to 94.4 K (+23.57 %) |
| Jun 02 2017 | ELGX | ENDOLOGIX INC /DE/ | Mitchell Robert D | President | Payment of Exercise | F | 4.79 | 2,183 | 10,457 | 334,969 | 337.2 K to 335 K (-0.65 %) |
| Jun 02 2017 | ELGX | ENDOLOGIX INC /DE/ | Mitchell Robert D | President | Grant | A | 0.00 | 18,083 | 0 | 337,152 | 319.1 K to 337.2 K (+5.67 %) |
| Jun 02 2017 | ELGX | ENDOLOGIX INC /DE/ | McDermott John D | Chief Executive Off ... | Option Exercise | A | 4.82 | 270,000 | 1,301,400 | 270,000 | |
| Jun 02 2017 | ELGX | ENDOLOGIX INC /DE/ | McDermott John D | Chief Executive Off ... | Grant | A | 0.00 | 140,000 | 0 | 797,169 | 657.2 K to 797.2 K (+21.30 %) |
| Jun 02 2017 | ELGX | ENDOLOGIX INC /DE/ | Lemaitre Dan | Director | Grant | A | 0.00 | 34,232 | 0 | 102,921 | 68.7 K to 102.9 K (+49.84 %) |
| Jun 02 2017 | ELGX | ENDOLOGIX INC /DE/ | Zenty III Thomas F | Director | Grant | A | 0.00 | 22,822 | 0 | 69,396 | 46.6 K to 69.4 K (+49.00 %) |
| Jun 02 2017 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Grant | A | 0.00 | 22,822 | 0 | 51,060 | 28.2 K to 51.1 K (+80.82 %) |
| Jun 02 2017 | ELGX | ENDOLOGIX INC /DE/ | Norwalk Leslie V | Director | Grant | A | 0.00 | 22,822 | 0 | 43,491 | 20.7 K to 43.5 K (+110.42 %) |
| Jun 02 2017 | ELGX | ENDOLOGIX INC /DE/ | Chavez Christopher G. | Director | Grant | A | 0.00 | 22,822 | 0 | 378,362 | 355.5 K to 378.4 K (+6.42 %) |
| Jun 02 2017 | ELGX | ENDOLOGIX INC /DE/ | WALLER GREGORY D | Director | Grant | A | 0.00 | 22,822 | 0 | 50,550 | 27.7 K to 50.6 K (+82.31 %) |
| Jun 02 2017 | ELGX | ENDOLOGIX INC /DE/ | NEELS GUIDO J | Director | Grant | A | 0.00 | 22,822 | 0 | 84,202 | 61.4 K to 84.2 K (+37.18 %) |